$110.01
0[0.00%]
At close: May 3
$110.12
0.1100[0.10%]
PreMarket: 4:08PM EDT
Jazz Pharmaceuticals
(NASDAQ:JAZZ)Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Earnings Estimates, EPS, and Revenue
Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS
$2.680
Quarterly Revenue
$902M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.8B
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/01/2024 | PM | JAZZ | Q1 | $3.95 | $4.18 | $2.68 | -35.89% | $892.81M | $953.90M | $901.98M | -5.44% | Get Alert |
| 02/28/2024 | PM | JAZZ | Q4 | -$0.07 | $5.16 | $5.02 | -2.71% | $972.12M | $1.01B | $1.01B | 0.20% | Get Alert |
| 11/08/2023 | PM | JAZZ | Q3 | $5.17 | $4.91 | $4.84 | -1.43% | $940.65M | $965.73M | $972.14M | 0.66% | Get Alert |
| 08/09/2023 | PM | JAZZ | Q2 | $4.30 | $4.43 | $4.51 | 1.81% | $932.88M | $942.86M | $957.32M | 1.53% | Get Alert |
| 05/10/2023 | PM | JAZZ | Q1 | $3.73 | $4.24 | $3.95 | -6.84% | $813.72M | $895.37M | $892.81M | -0.29% | Get Alert |
| 03/01/2023 | PM | JAZZ | Q4 | $4.21 | $0.32 | -$0.07 | -121.88% | $896.73M | $975.59M | $972.12M | -0.36% | Get Alert |
| 11/09/2022 | PM | JAZZ | Q3 | $4.20 | $4.66 | $5.17 | 10.94% | $838.12M | $939.06M | $940.65M | 0.17% | Get Alert |
| 08/03/2022 | PM | JAZZ | Q2 | $3.90 | $4.20 | $4.30 | 2.38% | $751.81M | $904.21M | $932.88M | 3.17% | Get Alert |
| 05/04/2022 | PM | JAZZ | Q1 | $3.92 | $3.83 | $3.73 | -2.61% | $607.58M | $853.52M | $813.72M | -4.66% | Get Alert |
| 03/01/2022 | PM | JAZZ | Q4 | $4.00 | $3.63 | $4.21 | 15.98% | $665.52M | $865.88M | $896.73M | 3.56% | Get Alert |
| 11/09/2021 | PM | JAZZ | Q3 | $4.31 | $3.31 | $4.20 | 26.89% | $600.89M | $832.52M | $838.12M | 0.67% | Get Alert |
| 08/03/2021 | PM | JAZZ | Q2 | $3.71 | $3.42 | $3.90 | 14.04% | $562.44M | $735.62M | $751.81M | 2.20% | Get Alert |
| 05/04/2021 | PM | JAZZ | Q1 | $0.45 | $3.74 | $3.92 | 4.81% | $534.73M | $611.49M | $607.58M | -0.64% | Get Alert |
| 02/23/2021 | PM | JAZZ | Q4 | $4.42 | $4.20 | $4.00 | -4.76% | $581.74M | $639.55M | $665.52M | 4.06% | Get Alert |
| 11/02/2020 | PM | JAZZ | Q3 | $4.10 | $4.08 | $4.31 | 5.64% | $537.70M | $577.58M | $600.89M | 4.04% | Get Alert |
| 08/04/2020 | PM | JAZZ | Q2 | $4.05 | $3.11 | $3.71 | 19.29% | $534.13M | $504.65M | $562.44M | 11.45% | Get Alert |
| 05/05/2020 | PM | JAZZ | Q1 | $1.47 | $0.67 | $0.45 | -32.84% | $508.19M | $543.59M | $534.73M | -1.63% | Get Alert |
| 02/25/2020 | PM | JAZZ | Q4 | $3.64 | $4.12 | $4.42 | 7.28% | $476.46M | $561.69M | $581.74M | 3.57% | Get Alert |
| 11/05/2019 | PM | JAZZ | Q3 | $3.58 | $3.59 | $4.10 | 14.21% | $469.37M | $525.16M | $537.70M | 2.39% | Get Alert |
FAQ
When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?
Jazz Pharmaceuticals (JAZZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 1, 2024 for Q1.
What were the latest earnings per share (EPS) for Jazz Pharmaceuticals (NASDAQ:JAZZ)?
Jazz Pharmaceuticals (JAZZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 1, 2024 for Q1 and the Actual EPS was $2.68, which missed the estimate of $4.18.
What were Jazz Pharmaceuticals’s (NASDAQ:JAZZ) revenues?
Jazz Pharmaceuticals (JAZZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 1, 2024 for Q1 and the Actual Revenue was $902M, which missed the estimate of $953.9M.
Browse earnings estimates, EPS, and revenue on all stocks.